◆英語タイトル:Intermountain Healthcare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013414
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, surgical services, behavioral health, neurosciences, and musculoskeletal and its clinical services cover dialysis, environmental, food and nutrition, clinical genetics institute, imaging, integrated care management, laboratory, nursing, pain, patient and provider publications, patient flow, patient safety, pharmacy, rehabilitation, and respiratory care. Intermountain Healthcare operates through hospitals and clinics at various locations including Burley, Smithfield, Tremonton, Logan, Providence, Brigham City, Heber City, among several others. Intermountain is headquartered in Salt Lake City, Utah, the US.
Intermountain Healthcare Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Intermountain Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 11
Ingram Medical Raises US$30 Million In Series B Venture Financing 12
Partnerships 13
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 13
Intermountain Healthcare Inc – Key Competitors 14
Intermountain Healthcare Inc – Key Employees 15
Intermountain Healthcare Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Corporate Communications 19
Nov 02, 2017: Empiric Health Announces Justin Schaper as Chief Technology Officer to Advance Evidence-Based Technology Offering 19
May 20, 2016: Dr. A. Marc Harrison Named Upcoming CEO of Intermountain Healthcare 20
Government and Public Interest 21
Nov 20, 2017: NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care 21
Jul 11, 2017: New Study Finds That Lymph Node Removal Isn’t Necessary For All Melanoma Patients 22
Jul 26, 2016: Obesity and Smoking Lead to Poorer Quality of Life for ARDS Patients Six Months After Discharge from Hospital, Study Finds 24
May 05, 2016: Study Finds Cardiac Ablation Doesn’t Reduce Atrial Fibrillation Risk For Patients With Syndrome 25
May 05, 2016: New Study Finds Patients With Atrial Fibrillation Who Are Treated With Common Blood Thinner Have Higher Rates of Dementia 26
May 05, 2016: Utah Study Finds Improvements in Warfarin Use for Atrial Fibrillation Treatment Necessary to Protect Kidney Function and Heart Health 28
Apr 02, 2016: Study Finds Elevated Levels of Newly Identified Inflammation Biomarker Offsets Benefits of Good Cholesterol 29
Product News 30
Oct 27, 2016: Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms 30
Aug 29, 2016: New Life-saving Technology at Intermountain Medical Center Improves Detection, Survival of Bladder Cancer 31
Other Significant Developments 32
May 23, 2017: Intermountain Healthcare Goes Live on the American Well Exchange 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Intermountain Healthcare Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Intermountain Healthcare Inc, Medical Devices Deals, 2011 to YTD 2017 9
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 11
Ingram Medical Raises US$30 Million In Series B Venture Financing 12
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 13
Intermountain Healthcare Inc, Key Competitors 14
Intermountain Healthcare Inc, Key Employees 15
Intermountain Healthcare Inc, Other Locations 16
Intermountain Healthcare Inc, Subsidiaries 17